Ignite Creation Date:
2024-05-06 @ 6:24 PM
Last Modification Date:
2024-10-26 @ 2:47 PM
Study NCT ID:
NCT05655312
Status:
RECRUITING
Last Update Posted:
2024-04-03
First Post:
2022-11-15
Brief Title:
MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma
Sponsor:
Perspective Therapeutics
Organization:
Perspective Therapeutics
Organization Data
Organization:
Perspective Therapeutics
Class:
INDUSTRY
Study ID:
VMT01-T101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Perspective Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None